Jag Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-11,185
Closed -$2.72M 122
2017
Q2
$2.72M Sell
11,185
-34,203
-75% -$8.04M 0.54% 39
2017
Q1
$10.8M Buy
45,388
+34,161
+304% +$7.96M 2.24% 19
2016
Q4
$2.36M Buy
11,227
+42
+0.4% +$8.7K 0.48% 46
2016
Q3
$2.58M Hold
11,185
0.5% 48
2016
Q2
$2.58M Sell
11,185
-22,041
-66% -$5.08M 0.56% 45
2016
Q1
$8.91M Sell
33,226
-15,584
-32% -$4.46M 1.82% 24
2015
Q4
$15.3M Buy
48,810
+11,658
+31% +$3.47M 2.85% 13
2015
Q3
$10.1M Buy
+37,152
New +$11.4M 1.92% 22

Other funds holding AGN

Jag Capital Management's AGN Position: Q3 2017 in Review

Jag Capital Management sold out of Allergan plc (AGN) in Q3 2017, closing a stake of 11,185 shares — an estimated $2.72M sold.

Jag Capital Management first reported a position in AGN in Q3 2015 and held it in 8 quarters. The position peaked at $15.3M in Q4 2015. 1,090 funds tracked by Wall St. Rank hold AGN as of Q3 2017.

  • Jag Capital Management reported no remaining Allergan plc position as of Q3 2017 after selling out during the quarter.
  • Jag Capital Management sold 11,185 Allergan plc shares in Q3 2017, an estimated $2.72M.
  • Jag Capital Management first reported a position in Allergan plc in Q3 2015 and held it in 8 quarters.
  • Jag Capital Management's Allergan plc position peaked at $15.3M in Q4 2015.
  • 1,090 funds tracked by Wall St. Rank held Allergan plc as of Q3 2017.

Based on Jag Capital Management's 13F filing for Q3 2017, filed 16 Oct 2017.